Home » Authors » Glen Harris

Glen Harris

Articles

ARTICLES

Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal

Nov. 1, 2011

No Abstract

Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline

Nov. 1, 2011

No Abstract

PDL Divestiture Continues in $170M Deal with EKR

Nov. 1, 2011

No Abstract

Phenomix Seeking $86M IPO to Push Diabetes Candidate

Nov. 1, 2011

No Abstract

Regeneron Signs Another Deal For A Potential $120M Payoff

Nov. 1, 2011

No Abstract

Arginetix, Immune Control Merge Two Corridors in Vascular Space

June 18, 2010

Alvine Brings in Another $21M to Fund Celiac Disease Studies

Sep. 16, 2009

NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials

Aug. 7, 2009

Infinity Halts Tumor Trial Due to High Mortality Data

April 16, 2009

Lean Sunesis Gets Flush with $43.5M Placement

April 2, 2009

View All Articles by Glen Harris

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...